DGAP-News: Aignostics Raises €14m Series A to Advance AI-powered Pathology
Recognizing that, Aignostics focuses on building leading AI models for the detailed analysis of tissue samples and associated metadata for its blue-chip pharma and biotech clients.
DGAP-News: Aignostics GmbH / Key word(s): Financing Aignostics Raises €14m Series A to Advance AI-powered Pathology 15.09.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. Aignostics Raises €14m Series A to Advance AI-powered Pathology
Berlin, Germany, 15th September 2022 ABOUT AIGNOSTICS
ABOUT WELLINGTON PARTNERS
15.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
1442783 15.09.2022 CET/CEST